Skip to main content
. 2020 Dec 16;9(12):4067. doi: 10.3390/jcm9124067

Figure 3.

Figure 3

Distribution of the respective outcomes depending on the disease modifying therapies. (a) Distribution of different outcomes per DMT; (b) Number of non-hospitalized, hospitalized, ventilated, and deceased patients. DMF: dimethyl-fumarate; Hospit.: hospitalized; ICU: intensive care unit; NIV: non-invasive ventilation. Others: stem cell therapy (n = 5), immunoglobulins (n = 4), mycophenolate mofetil (n = 3), azathioprine (n = 1), cyclophosphamide (n = 1), methotrexate (n = 1).